Increasing payers benefits from parallel trade: Observations from Scandinavia and policy proposals for Europe


Our case studies from three Scandinavian countries have shown that parallel trade is not lowering drug expenditures to the same extent in all countries. While relative price advantages of parallel traded drugs are sizeable in Sweden, they are very low in Norway.


Policy Proposal Medicine Control Agency Parallel Trade Durable Consumer Good Price Convergence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Birkhäuser Verlag AG 2008

Personalised recommendations